Assessing medication effects in the MTA study using neuropsychological outcomes
Jeffery N Epstein1, C Keith Conners, Aaron S Hervey
1Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. epste002@mc.duke.edu
Insights
Stimulant medication for attention deficit/hyperactivity disorder (ADHD) impacts reaction time (RT) and RT variability. This study found that medication slows RT but reduces variability, highlighting the need for advanced analytical models.
Area of Science:
- Neuroscience
- Child Psychology
- Psychopharmacology
Background:
- Attention deficit/hyperactivity disorder (ADHD) is associated with deficits in reaction time (RT) and RT variability.
- Limited research exists on stimulant medication's effects on these neuropsychological measures in children with ADHD.
Purpose of the Study:
- To investigate the impact of stimulant medication on RT and RT variability in children with ADHD.
- To explore advanced analytical methods for assessing these outcomes.
Main Methods:
- Utilized data from 316 children in the Multimodal Treatment Study of Children with ADHD (MTA).
- Administered the Conners' Continuous Performance Test (CPT) at 24 months.
- Analyzed standard CPT outcomes and Ex-Gaussian distributional model indicators (mu, sigma, tau) for RT.
Main Results:
- Stimulant medication demonstrated significant effects across all neuropsychological outcome measures.
- Ex-Gaussian analysis indicated that stimulant medication slows mean reaction time (RT).
- Stimulant medication was found to reduce RT variability in children with ADHD.
Conclusions:
- Accurate modeling of distributional patterns, including positive skew, is crucial for understanding ADHD.
- Findings provide insights into theoretical models of ADHD and the effects of stimulant treatment.
Background:
While studies have increasingly investigated deficits in reaction time (RT) and RT variability in children with attention deficit/hyperactivity disorder (ADHD), few studies have examined the effects of stimulant medication on these important neuropsychological outcome measures.
Methods:
316 children who participated in the Multimodal Treatment Study of Children with ADHD (MTA) completed the Conners' Continuous Performance Test (CPT) at the 24-month assessment point. Outcome measures included standard CPT outcomes (e.g., errors of commission, mean hit reaction time (RT)) and RT indicators derived from an Ex-Gaussian distributional model (i.e., mu, sigma, and tau).
Results:
Analyses revealed significant effects of medication across all neuropsychological outcome measures. Results on the Ex-Gaussian outcome measures revealed that stimulant medication slows RT and reduces RT variability.
Conclusions:
This demonstrates the importance of including analytic strategies that can accurately model the actual distributional pattern, including the positive skew. Further, the results of the study relate to several theoretical models of ADHD.
